Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic Frozen Shoulder Patients.

NCT ID: NCT05967923

Last Updated: 2023-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-05

Study Completion Date

2024-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients will be divided randomly into 3 groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be allocated from out patient clinics of Qena university hospitals Then they will be randomly assigned to three groups, every one will contain 30 patients of both gender, with age range between 45 and 60 years old

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Group (a) Group (b) Group (c)
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group (a)

Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Group Type EXPERIMENTAL

Shock wave therapy

Intervention Type RADIATION

Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Routine physical therapy program

Intervention Type OTHER

Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Group (b)

Patients in this group will receive low level lazer therapy three times per week for four weeks in addition to routine physical therapy program.

Group Type EXPERIMENTAL

Low level lazer therapy

Intervention Type RADIATION

Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.

Routine physical therapy program

Intervention Type OTHER

Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Group (c)

Patients in this group will receive only routine physical therapy program.

Group Type EXPERIMENTAL

Routine physical therapy program

Intervention Type OTHER

Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shock wave therapy

Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Intervention Type RADIATION

Low level lazer therapy

Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.

Intervention Type RADIATION

Routine physical therapy program

Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Non Non

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with diabetes mellitus.
* patients with frozen shoulder due to diabetes mellitus.
* patients age ranged between 45 and 60 years old.
* cooperative patients.

Exclusion Criteria

* patients with un-controlled hypertension.
* patients sensetive to shock wave or lazer irradiation.
* Patients with infectious skin diseases.
* un-cooperative patients.
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South Valley University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shymaa yussuf abo zaid

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shymaa yussuf abo zaid

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shymaa Yussuf Abo zaid

Role: CONTACT

01010941685 ext. 01091631018

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shymaa Y Abo zaid

Role: primary

01010941685 ext. 01091631018

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T- ORTH-06/2023-516

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.